BARÜ’s Project Explores New Pancreatic Cancer Treatment Methods

Yayın Tarihi : 25/07/2024
Bartın University (BARÜ), with the support of TÜBİTAK, will explore chemotherapy-resistant pancreatic cancer cells to develop new treatment combinations.

The project led by Research Assistant Kübra Sena Baş Topcu from the Molecular Biology and Genetics Department of Bartın University (BARÜ) and supervised by Associate Professor Dr. Ercan Çaçan from Tokat Gaziosmanpaşa University's Faculty of Science and Letters, Molecular Biology and Genetics Department, has been approved for support under TÜBİTAK's 1002-A Rapid Support Program.

Titled “Pankreas Kanserinde İmmün Checkpoint HVEM’in Düzenleyici Rolünün Sistem Biyolojisi Yaklaşımıyla Araştırılması” (Investigating the Regulatory Role of Immune Checkpoint HVEM in Pancreatic Cancer Through a Systems Biology Approach), the project will analyze the effects of the HVEM (Herpesvirus Entry Mediator) molecule, a critical component of the immune system, on pancreatic cancer cells using modern methods.

Aimed at developing new strategies in immunotherapy, the research will also involve contributions from Associate Professor Dr. Yavuz Erden from BARÜ’s Molecular Biology and Genetics Department and Research Assistant Kübra Temiz from the Biotechnology Department.


SON Haberler

  • Over 15,000 people visited the 7th International R&D Project Market at BARU

  • Science and Technology Enthusiasts from 9 Countries Gather at BARU

  • BARU Ranks in the Top 500 in the World and 2nd in Turkey in “Research Quality”

  • BARÜ Awarded the "Contribution to Local Development" Prize

  • The applications for the BARÜ 7th International R&D Project Market are now open!

  • BARU's Quotas Are Nearly 100% Filled, and Admission Scores Have Increased

  • BARU Collaborates with Rosario University from Colombia

  • BARU Continues to Expand Its Science Diplomacy Network

  • BARÜ's national weightlifter Muhammed Furkan Özbek made us proud at the Olympics

  • TÜBİTAK Supports BARÜ’s Renewable Energy Project